The effects of intravenous lidocaine on the refractory periods of the atrium, AV node and right ventricular myocardium were studied using His bundle recordings and the extrastimulus technique with and without atrial and ventricular pacing. The drug was administered in an intravenous bolus dose of 1mg/Kg followed by an infusion of 100micrograms/ Kg/min. The AH, HV intervals and resting sinus cycle length as well as functional and effective refractory periods of atrium, AV node and right ventricle were measured before and 5min afrer bolus injection of lidocaine. Neither of the refractory periods nor AH and HV intervals changed significantly following administration of lidocaine. The result of this first study in children is in agreement with previous reports of the effects of lidocaine on the cardiac conduction system in adults.
A LTHOUGH lidocaine is routinely used for the emergency treatment of ventricular arrhythmias in adults1)-3) and children, there are a few electrophysiologic studies concerning its effect in adults4)-7) and to date we are not aware of any systematic evaluation of the drug in children. The purpose of this report is to present the cardiac electrophysiologic effects of lidocaine in the pediatric age group.
MATERIALS AND METHODS
Studies were performed in 14 children (age range 14 months to 14 years) during diagnostic cardiac catheterization. Abbreviations: Dx=diagnosis; ERPAVN=effective refractory period of the AV node; FRPAVN=functional refractory period of the AV node; ERPA=effective refractory period of the atrium; FRPA=functional refractory period of the atrium; ERPRV=effective refractory period of the right ventricle; FRPRV =functional refractory period of the right ventricle; AH=AH interval; HV=HV interval; RR=resting sinus cycle length; S1-S1=pacing cycle length. ASD= Electrophysiologic procedure: Informed consents were obtained from all parents. None of the children were on cardioactive drugs before the study. The studies were performed in fasting state. All patients received premedication consisting of meperidine 15mg/Kg (max 30mg), promethazine 4mg/10Kg (max 10mg), and chlorpromazine 4mg/ 10Kg (max 10mg) im, 1 hour before the study.
Up to 3 bipolar electrode catheters and 1 polyethylene catheter (for administration of drug) were introduced into either the superficial saphenous vein or the femoral vein on one side. Occasionally a right antecubital vein was also used. sec. Initially a recording was made without pacing. The patients were subsequently paced at a cycle length assuring atrial capture. Extrastimulus was then introduced in 10msec decrements following every 8th paced beat and continued until no intracardiac response occurred. After atrial pacing the right ventricle was paced and right ventricular functional and effective refractory periods were measured as well. Following this procedure lidocaine was administered intravenously in a dose of 1mg/Kg as initial bolus injection followed by a continuous drip of 100micrograms/Kg/min.8) Five min after administration of the bolus, unpaced tracings were recorded and then the entire procedure using extrastimulus technique was repeated. The following pre-and post-lidocaine intervals were measured; RR at rest, AH, HV, effective and functional refractory periods of the AV node (ERPAVN, FRPAVN), the atrium (ERPA, FRPA), and the right ventricle (ERPRV, FRPRV). Intervals were defined and measured as described by Denes et al.9) Due to variabilities of the heart rates due to different cycle lengths for atrial and ventricular capture and because of the effect of cycle lentgh on refractory periods9), 10), pacing cycle length was not changed before and after lidocaine, thus allowing each patient to serve as his own control.
Definitions9), 10): FRPRV was the shortest attainable V1-V2 during ventricular pacing. FRPAVN was the shortest attainable H1-H2. FRPA was the shortest attainable A1-A2. ERPRV was the longest S1-S2 at which V2 failed to be elicited. ERPAVN was the longest H1-H2 at which H2 failed to be elicited. ERPA was the longest S1-S2 at which atrial capture failed to occur.
When the FRPA was longer than the ERPAVN, the refractoriness of the system was atrial-limited. In these cases the ERPAVN was considered equal to or less than the FRPA.
Analysis of data: RR, AH and HV intervals before and after lidocaine without pacing were measured. RR and HV intervals were compared for the entire group and Student's t-test was applied to the values. Since AH interval is affected by heart rate, whereas HV is not,11), 12) the former was corrected for heart rate using Bazett's formula. Since each patient served as his own control and because of the effect of cycle length on refractory periods, the results of pre-and post-lidocaine studies could not be compared as a group mean and standard deviation (SD) of the values. Therefore percent change of refractory periods before and after lidocaine was calculated for each case and p values were calculated for mean percent change compared with the control values.
RESULTS
The drug was well tolerated in all patients and no serious untoward effects were noted. The pertinent data are summarized in The effect of lidocaine on the heart rate has been variable. In some reports it has increased the heart rate, whereas in in vitro models it decreases the rate of spontaneous depolarization.6) In our patients, in contrast to adults, the trend of the change was towards a decrease in heart rate, however this change again was not statistically significant. In summary, lidocaine administered in a therapeutic dose of 1mg/Kg iv bolus, followed by 100microgram/Kg/min iv drip did not change the electrophysiologic properties of the cardiac conduction system nor the right ventricular myocardium in children. This is in accord with previous reports of the effects of lidocaine in adults. The lack of effect on electrophysiologic properties of the cardiac conduction system, however, does not exclude the possibility of significant effects on the refractory periods and conduction properties of diseased myocardium.3)
